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Mycobacterium bovis (M. bovis), the most common pathogens of tuberculosis (TB), is
virulent to human and cattle, and transmission between cattle and humans warrants
reconsideration concerning food safety and public health. Recently, efforts have begun
to analyze cellular proteomic responses induced byMycobacterium tuberculosis (M. tb).
However, the underlying mechanisms by which virulent M. bovis affects human hosts
are not fully understood. For the present study, we utilized a global and comparative
labeling strategy of isobaric tag for relative and absolute quantitation (iTRAQ) to assess
proteomic changes in the human monocyte cell line (THP-1) using a vaccine strain and
two virulent strains H37Rv and M. bovis. We measured 2,032 proteins, of which 61
were significantly differentially regulated. Ingenuity Pathway Analysis was employed to
investigate the canonical pathways and functional networks involved in the infection.
Several pathways, most notably the phagosome maturation pathway and TNF signaling
pathway, were differentially affected by virulent strain treatment, including the key proteins
CCL20 and ICAM1. Our qRT-PCR results were in accordance with those obtained from
iTRAQ. The key enzyme MTHFD2, which is mainly involved in metabolism pathways,
as well as LAMTOR2 might be effective upon M. bovis infection. String analysis also
suggested that the vacuolar protein VPS26A interacted with TBC1D9B uniquely induced
by M. bovis. In this study, we have first demonstrated the application of iTRAQ to
compare human protein alterations induced by virulentM. bovis infections, thus providing
a conceptual understanding of mycobacteria pathogenesis within the host as well as
insight into preventing and controlling TB in human and animal hosts’ transmission.
Keywords: M. tb, M. bovis, THP-1 cell, iTRAQ, proteomics, pathway analysis
INTRODUCTION
Tuberculosis (TB) is an infectious disease that greatly impacts human and animal health worldwide.
TB is caused by members of the Mycobacterium tuberculosis (M. tb) complex (MTBC), of which
M. tb is a primary causative agent in humans. A recent report on global tuberculosis from the
World Health Organization (WHO) indicated that 10.4 million people became ill and that 1.8
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million died from TB in 2015 (World Health Organization,
2016). In a study in which cattle were artificially infected with
two M. tb strains, it was confirmed that M. tb is virulent to
cattle (Chen et al., 2013). Tuberculosis in animals is primarily
observed in cattle and other bovids, for which the disease is
generally referred to as bovine tuberculosis (bTB) and is mainly
caused by Mycobacterium bovis (M. bovis). Animal tuberculosis
bears a zoonotic potential and is therefore a public health
concern (Cosivi et al., 1998; Renwick et al., 2007; Michel et al.,
2010; Koul et al., 2011). Thus, M. tb and M. bovis are the
most common pathogens within the MTBC (Ernst et al., 2007).
Although M. bovis is the main causative agent of bTB, it has
the broadest host range among all MTBC members (Meikle
et al., 2011). Globally, most cases of zoonotic TB caused by M.
bovis have been anecdotally reported, including TB in humans
that is usually associated with extrapulmonary TB (Ayele et al.,
2004; Müller et al., 2013; Gallivan et al., 2015; Jiang et al.,
2015; El-Sayed et al., 2016). M. bovis resulted from genomic
evolutionary reduction of M. tb, although the two species share
99.95% genomic identity (Garnier et al., 2003; Bigi et al., 2016).
Since 1921, M. bovis bacillus Calmette-Guérin (BCG) has been
recognized as an important and available vaccine to prevent
tuberculosis worldwide (Mahairas et al., 1996). It is an attenuated
strain ofM. bovis developed by Calmette and Guérin, which lost
its virulence after 230 passages over a period of 13 years (Hsu
et al., 2003; Seki et al., 2009). AsM. bovis causes zoonotic diseases
(Dye and Williams, 2010), it is necessary to have a conceptual
and clear understanding of mycobacteria transmission dynamics
and pathogenesis within populations and between hosts, thus
providing insight into better improvement of TB control through
novel and collaborative research and public health efforts.
Macrophages (M8s) are the primary effector cells responsible
for killing M. tb through various mechanisms, including
the induction of toxic anti-microbial effectors, stimulation of
microbe intoxication mechanisms, apoptosis, lipid mediators,
microRNAs, and cytokines (van Crevel et al., 2002; Rajaram
et al., 2014; Weiss and Schaible, 2015). However, MTBC can
evade host immunity to create a favorable environment for
intracellular replication via their lipids, inhibition of phagosome-
lysosome fusion and phagosome acidification, hijacking host
cell signaling, downregulation of host gene expression, and
formation of granuloma (Cosma et al., 2003; Rohde et al.,
2007; Davis and Ramakrishnan, 2009; Meena, 2010; Arbues
et al., 2015; Chandran et al., 2015; Colonne et al., 2016).
Therefore, quantitative and comparative proteomic analyses
have been used to provide complementary information about
host responses to MTBC infection, particularly M. tb (Giri
et al., 2010; Schmidt and Völker, 2011; He et al., 2012; Jamwal
et al., 2013; Kunnath-Velayudhan and Porcelli, 2013; Petriz and
Franco, 2014). Researchers have identified eight intraphagosomal
expressed proteins of the BCG strain during infection with
macrophages (Singhal et al., 2016). Such proteomic data have
provided enhanced characterization of MTBC and host-derived
targets to better improvement of TB control. While the vast
majority of proteomic research about virulent M. bovis-host
interaction focused on biomarkers during infection of cattle,
MTBC natural reservoir hosts, such as the Eurasian wild boar
(Sus scrofa), and clinical specimens have also been assessed
(Naranjo et al., 2007; Garton et al., 2008; Seth et al., 2009; Blanco
et al., 2014; Lamont et al., 2014; Young et al., 2014; Esterhuyse
et al., 2015; López et al., 2016).
M. bovis is responsible for great economic losses and cattle-
to-human transmission and represents a severe threat to public
health (Cosivi et al., 1995; Fogel, 2015). Since the pathogenesis
of bTB is not as well understood as human tuberculosis, we
employed proteomic analyses by examining activated THP-1 cells
infected with the vaccine strain BCG and two virulent MTBC
strains, including M. tb-H37Rv and M. bovis, by isobaric tag for
relative and absolute quantitation (iTRAQ). We identified and
measured 2,032 proteins with two or more peptides at >99%
confidence and found that 61 were significantly regulated. There
also were major differences in the proteins and pathways induced
by the virulent MTBC strains when compared to the vaccine
strain BCG. H37Rv and M. bovis both induced significant up-
regulation of several proteins in the TNF signaling pathway.
Immunological disease, as well as inflammatory response and
disease, were more prominent upon infection of cells with
virulent H37Rv and M. bovis than the BCG strain. This
work serves as an enhancement of the understanding that M.
bovis affects proteins obtained from human host cells. These
results may provide useful insights in understanding MTBC
pathogenesis, particularly M. bovis, revealing novel biomarkers
that may be critical to TB cattle-to-human transmission and
diagnosis. Such foundational knowledge we have obtained from
this study may drive more efficacious treatment and hopefully
eventual eradication of TB.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
The M. tb reference strain H37Rv (ATCC 27294), BCG Tokyo
strain (ATCC 35737), and M. bovis (ATCC 19210) were
kindly provided by Dr. Chuanyou Li, Beijing Tuberculosis &
Thoracic Tumor Research Institute (Beijing, China). All strains
were cultured to mid-log phase in Middlebrook 7H9 medium
(Becton Dickinson and Company, Franklin Lakes, NJ, USA)
supplemented with 10% oleic acid, albumin, dextrose, and
catalase medium (OADC) (Becton Dickinson and Company)
and 0.05% Tween 80 (Amresco Inc., Solon, OH, USA) with
agitation. Cultures were maintained in a biosafety level 3 facility
at Huazhong Agricultural University (Wuhan, China) and stored
at −80◦C. Bacteria were harvested from the culture medium
by centrifugation at 4,000 g for 10 min washed once in 1,640
medium, resuspended in 1,640 to an OD600 of 1, equivalent to
3× 108 bacteria/ml. Before measuring the absorbance at 600 nm,
a syringe connected to a sterile needle was used to scatter the
bacterial clumps.
For the colony counting assay, bacteria were serially diluted
10-fold with Middlebrook’s 7H11 medium and 0.1 ml of each
dilution was transferred to 7H11 plates. Bacteria were grown
for about 4 weeks until the colonies were suitable for counting
by eye. Bacterial concentration was recorded as c.f.u. ml−1.
CFUs were calculated from the actual colony counts obtained to
guarantee the same initial infection dose. Detailed protocols and
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culture conditions are described elsewhere (Kumar et al., 2010;
Wassermann et al., 2015).
Cell Culture and Infection
The human monocyte cell line THP-1 was cultured in RPMI
1,640 supplemented with 2 mM L-glutamine and 10% FBS
(Hyclone, GEHealthcare Life Science, Grand Island, USA). THP-
1 cells were activated using 100 ng/mL phorbol myristate acetate
(PMA) and incubated at 37◦C in a 5% CO2 atmosphere for 48
h. To reduce the effect of PMA from THP-1 cells, the medium
was replaced, and incubation was continued for another 8 h. They
were then infected with H37Rv, M. bovis, or BCG at an MOI of
10 (10 bacteria to one cell) (Hmama et al., 1998; Chen et al., 2013;
Zhang et al., 2013;Wassermann et al., 2015). After 24 h, cells were
collected, washed three times with ice-cold phosphate-buffered
saline (PBS) and processed for iTRAQ analysis or total RNA
extraction. Three independent experiments were performed.
Protein Preparation, Protein Digestion, and
iTRAQ Labeling
TheMTBC-infected andmock-infected cells in 10 cm cell culture
flasks were collected using cell scrapers and suspended in 400 µL
lysis buffer containing 8 M urea, 30 mM HEPES, 1 mM PMSF, 2
mMEDTA, and 10mMDTT. Further lysate debris was moved by
centrifugation at 20,000 g for 30 min at 4◦C after ultrasonication
treatment for 5 min (pulse on: 2 s and pulse off: 3 s; power: 180
W). The supernatants were reduced with 10 mM DTT at 56◦C
for 1 h and alkylated with 55 mM IAM in the darkroom for 1
h. The protein mixtures were precipitated by adding 4× volume
of chilled acetone at −20◦C overnight. After centrifugation at
20,000 g for 30 min at 4◦C, the pellet was dissolved in 0.5 M
TEAB (Applied Biosystems, Milan, Italy) with 0.1% SDS via
an ultrasonication treatment for 5 min. After centrifuging at
20,000 g for 30 min at 4◦C, an aliquot of the supernatant was
taken to determine protein concentration via the Bradford assay
(Sangon Biotech, Shanghai, China).
For each sample, total protein (100 µg) was digested with 3.3
µl of trypsin (1 µg/µl) (Promega, Madison, WI, USA) at 37◦C
for 24 h. After trypsin digestion, peptides were dried via vacuum
centrifugation. Peptides were reconstituted in 0.5 M TEAB and
processed according to the manufacturer’s instructions (Applied
Biosystems). Briefly, one unit of iTRAQ reagent (AB Sciex,
Foster City, CA, USA) was thawed and reconstituted in 24 µL
isopropanol. Samples were labeled with the iTRAQ tags as follow:
BCG-infected samples (tag 115), H37Rv-infected samples (tag
116), M. bovis-infected samples (tag 117), and mock-infected
samples (tag 118). The peptides were then incubated at room
temperature for 2 h. The labeled samples were then mixed and
dried with a rotary vacuum concentrator.
LC-MS/MS Analysis
Strong cation exchange (SCX) chromatography (Phenomenex,
USA) was performed with an LC-20AB HPLC pump system
(Shimadzu, Kyoto, Japan) to separate samples. The iTRAQ-
labeled peptide mixtures were reconstituted and dissolved in
buffer A (10 mM KH2PO4 in 25% ACN, pH 3.0) and loaded
onto a 4.6 × 250 mm Ultremex SCX column containing 5 µm
particles (Phenomenex). The peptides were eluted at a flow rate
of 1 mL/min with a gradient of buffer A for 30 min, 5–50%
buffer B (10 mM KH2PO4 and 2 M KCl in 25% ACN, pH 3.0)
for 27 min, and 60–100% buffer B for 15 min. The system was
then maintained at 100% buffer B for 1 min before equilibrating
with buffer A for 10 min prior to the next injection. The eluted
peptides were desalted with a Strata X C18 column (100 × 75
mm; 5 µm particles; 300 Å aperture; Phenomenex, USA) and
vacuum dried.
The fractions above were dissolved in aqueous solution
containing 0.1% FA and 2%ACN and then centrifuged at 12,000 g
for 10 min at 4◦C. Five micrograms supernatant was loaded on
an LC-20AD nano HPLC (Shimadzu, Kyoto, Japan) by the auto
sampler onto a 2 cm C18 trap column (inner diameter 200 µm,
Waters), and the peptides were eluted onto a resolving 10 cm
analytical C18 column (inner diameter 75 µm, Waters). The
mobile phases used were composed of solvent A (0.1% FA and
5% ACN) and solvent B (0.1% FA and 95% ACN). The gradient
was run at 400 nL/min for 48min at 5–80% solvent B, followed by
running a linear gradient to 80% for 7 min, maintained at 80% B
for 3 min, and finally returned to 5% in 7 min. The peptides were
subjected to nano electrospray ionization followed by tandem
mass spectrometry (MS/MS) in a Q EXACTIVE (Thermo Fisher
Scientific, San Jose, CA, USA) coupled to the HPLC. Intact
peptides were detected in the Orbitrap at a resolution of 70,000
and a mass range of 350−2,000 m/z. Peptides were selected for
MS/MS using high-energy collision dissociation (HCD), and ion
fragments were detected in the Orbitrap at a resolution of 17,500.
The electrospray voltage applied was 1.8 kV. MS/MS analysis was
required for the 15 most abundant precursor ions, which were
above a threshold ion count of 20,000 in the MS survey scan,
including a following dynamic exclusion duration of 15 s.
Bioinformatics and Data Analysis
Raw data files acquired from the mass spectrometers were
converted intoMGF files using 5,600MS converter, and theMGF
files were searched. Protein identification was performed using
the Mascot search engine (Matrix Science, London, UK; version
2.3.0) against the Uniprot _2015_human database (containing
20,194 sequences). For protein identification, a mass tolerance
of 15 ppm was permitted for intact peptide masses and 0.05
Da for fragmented ions, with allowance for one missed cleavage
in the trypsin digests. Gln → Pyro-Glu (N-term Q), oxidation
(M), and deamidated (NQ) were potential variable modifications
and carbamidomethyl (C), iTRAQ 8plex (K), iTRAQ 8plex (Y),
iTRAQ 8plex (N-term) were fixed modifications. Specifically,
an automatic decoy database search was performed in Mascot
by choosing the decoy checkbox in which a random sequence
of the database is generated and tested for raw spectra as
well as the real database. To reduce the probability of false
peptide identification, only peptides with significance scores
(≥20) at the 99% confidence interval as determined by a Mascot
probability analysis were included. In addition, each confident
protein identification involved at least one unique peptide. The
quantitative protein ratios were weighted and normalized by the
median ratio in Mascot. Statistical significance analyses were
evaluated using two-way ANOVA. For comparison between
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samples, a protein with a ratio of mean fold change >1.2 (or
<0.83) with an Exp pr > 0.05 and a Group pr < 0.05 was
regarded as differentially expressed (Exp pr, three-experiment
p-value; Group pr, group p-value; Fold Change = Experiment +
Group+ Error).
Gene Ontology (GO) analysis was conducted using the
Blast2GO program against the non-redundant protein database,
and function characterization, biological network, pathway
analysis were all performed using the Ingenuity Pathway
Analysis software (IPA, http://www.ingenuity.com). The
probable interacting partners were predicted using the STRING-
10 server (http://string.embl.de/). STRING is a database of both
known and predicted protein-protein interactions. These include
direct (physical) and indirect (functional) associations, which
are derived from four separate sources: genomic context, high-
throughput experiments, co-expression, and prior knowledge.
A network was made at a medium confidence level (0.400),
allowing all active prediction methods (Sharma et al., 2016).
RNA Extraction and Real-Time PCR
Analysis
Total cellular RNA was extracted from MTBC-infected and
mock-infected THP-1 cells using the TRIzol reagent (Invitrogen)
according to the manufacturer’s protocol. After the RNA was
reverse-transcribed to first-strand cDNA using oligo (dT) as the
primer (Invitrogen), quantitative real-time PCR was performed
using an Applied Biosystems ViiA 7 real-time PCR system.
Reactions were each 10 µl containing 50 ng of cDNA, 2 ×
FIGURE 1 | The general work flow.
SYBR Green Master Mix Reagent (Applied Biosystems), and 100
nM of gene-specific primers. The thermocycling conditions were
95◦C for 5 min, and 40 cycles at 95◦C for 30 s, 60◦C for 30 s,
and 72◦C for 30 s. Amplification specificity was assessed using
melting curve analyses. Transcript abundances were normalized
to GAPDH, which served as the internal control. The primers
used are listed in Table S1. The degree of expression change was
calculated using the 2−11Ct method. Each cDNA sample was
amplified in triplicate. The data analysis was performed also using
the Applied Biosystems ViiA 7 real-time PCR system software
(Applied Biosystems).
Statistical Analysis
All statistical analyses were performed using the GraphPad Prism
software (version 6.02). Values are showed as mean ± standard
deviation (SD), p< 0.05 was considered statistically significant.
FIGURE 2 | Venn diagrams show the overlap of quantified proteins.
FIGURE 3 | Venn diagrams display the overlap of differentially
expressed proteins.
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RESULTS
We employed label-free quantitative proteomics to analyze whole
cell lysates harvested from THP-1 infected with either M. bovis,
M. tb-H37Rv, or BCG strains, and biological triplicates were
performed (Figure 1). We quantified 2,032 proteins in each
group, resulting in a total of 15,139 unique peptides from these
12 samples (we mock-infected cells also), however, 283 unique
peptides were not detected in this study (Table S2).
M. bovis, H37Rv, and BCG Induce Different
Host Protein Regulation
In this study, we employed the use of human monocyte THP-
1 cells after first differentiating them with PMA. The iTRAQ
data showed that a total of 2,481, 2,569, and 2,608 proteins were
quantified for three replicates, which were expressed as run 1, run
2, and run 3, respectively (Figure 2). Among them, 2,032 proteins
were common in all three biological replicates. Significant
up/down regulations between samples were determined by a
mean fold change >1.2 (or <0.83) with an Exp pr > 0.05 and
a Group pr< 0.05 for peptide quantification. In total, 61 proteins
were significantly up or down-regulated during MTBC infection
(Figure 3).
Specifically, 26 proteins were up-regulated and 4 proteins
were down-regulated during M. bovis infection. Meanwhile, 23
proteins were up-regulated and 11 proteins were down-regulated
during H37Rv infection; 9 proteins were up-regulated and 2
proteins were down-regulated during BCG strain infection. In
comparison with the uninfected cells, there was no common
protein among those our MTBC-infected groups (Table 1).
Several common proteins were identified that altered host
cells among our three strains. Only one host protein, regulator
complex protein LAMTOR2, was up-regulated by M. bovis
and BCG infections but not by H37Rv. Four host proteins
(three were up-regulated and only ACTBL2 was down-regulated)
were differentially regulated by H37Rv and BCG infections
and not by M. bovis infection. The three up-regulated host
proteins were RPL19, RPL13, and MT-ND4. Nine host proteins
(seven were up-regulated and two were down-regulated) were
differentially regulated by H37Rv and M. bovis infections but
not by BCG infection. These seven up-regulated host proteins
included ICAM1, APOE, CCL20, KRT9, DERL1, SOD2, and
NCF1. The two down-regulated proteins were TMSB4X and
TMSB10.
Several proteins were differentially regulated by variant
sources of mycobacteria. M. bovis infection induced the up-
regulation of 19 proteins (including VPS26A, RBM17, REP15,
CMTM6, YARS2, NDRG1, and RNF20), but H37Rv or BCG
infection did not induce significant alterations in the levels of
these proteins. Conversely, H37Rv infection induced the up-
regulation of two interferon-induced proteins (IFIT1 and IFIT3)
and the down-regulation of eight other proteins (including
FIGURE 4 | Comparison of GO term annotation for significantly regulated proteins. (A) Molecular Function, (B) biological process, (C) cellular component,
and (D) protein class.
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S100A6, FABP4, FABP5, GABARAPL2, and LGALS1), but
M. bovis or BCG infection induced non-significant changes in
the levels of these proteins. Meanwhile, five host proteins were
differentially up-regulated (including ATP6V0C and SEC61A1),
and only one was down-regulated (PEF1) by BCG infection but
not by H37Rv orM. bovis infection.
Functional Ontology Classification and
Bioinformatics Analyses of Differentially
Regulated Proteins
The differentially expressed proteins were cataloged into
different molecular functions (Figure 4A), biological processes
(Figure 4B), cellular components (Figure 4C), and protein
class (Figure 4D) by searching the Gene Ontology and
Uniprot databases. Differentially regulated M. bovis-infected
cell proteins were found to mainly localize to metabolism,
enzymatic activity, and cell part. Among 34 modulated proteins
in the H37Rv-infected samples, these proteins were mainly
implicated in metabolic processes, as well as BCG-induced host
proteins. Together, the GO annotation comparison provided a
comprehensive overview of differences regarding THP-1 infected
with virulent H37Rv and M. bovis strains and the BCG vaccine
strain, proteins which may be important in TB pathogenesis and
transmission.
FIGURE 5 | Functional characterization of significantly altered proteins in THP-1 cells infected with MTBC strain H37Rv, M. bovis, or BCG. (A) Top
canonical pathways, (B) diseases and disorders, (C) molecular and cellular functions, (D) physiological system development and functions, and (E) toxicity functions.
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FIGURE 6 | The detailed view of the top-score networks. Red indicates significantly up-regulated proteins, and green indicates significantly down-regulated
proteins. White indicates the proteins that were not identified in our data. The color depth reflects the fold-change of proteins. The shapes are indicative of the
molecular class. Lines with arrows connecting between the molecules indicate molecular relationships. Solid lines indicate direct interactions, and dashed lines
indicate indirect interactions. (A) The top-score IPA network of BCG infection: cellular development, cellular growth and proliferation, cell death and survival, (B) the
top two IPA networks of H37Rv infection: cellular movement, hematological system development and function, and immune cell trafficking (left); cancer, cell death,
and survival, and cellular movement (right), (C) the top two IPA networks of M. bovis infection: free radical scavenging, hereditary disorder, and immunological disease
(left); cell death and survival, organismal injury and abnormalities, and tissue morphology (right). Additional networks are depicted in Table S4.
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To better analyze the function characterization and biological
processes of relevant proteins, the Uniprot accession numbers
and ratios (+Strain/Mock) of all differentially expressed proteins
were uploaded into the IPA software. According to the function
classification, all the differentially expressed proteins could
be classified into five distinctive functional settings: (A) top
canonical pathways; (B) diseases and disorders; (C) molecular
and cellular functions; (D) physiological system development
and functions; (E) toxicity Functions (shown in Figure 5 and
Table S3, p < 0.05). These proteins were involved in various
biological processes and functions, including cancer, immune
cell trafficking, immunological disease, inflammatory disease,
cell death and survival, protein trafficking, metabolic disease,
cell-to-cell signaling and interaction, and infectious diseases.
To note, immunological disease, as well as inflammatory
response and disease, were more prominent upon infection
of cells with virulent H37Rv and M. bovis than the BCG
strain.
The IPA tool was used to explore the potential, specific
functional networks for proteins that changed in abundance.
In total, 38 protein networks were mapped based on these
differentially regulated proteins uponM. bovis, H37Rv, and BCG
infection, respectively (Table S4). To investigate the underlying
biologically functional differences that may be related to MTBC
infection, five strongly represented networks of interest were
depicted. For BCG infection, the top-score network was cellular
development, cellular growth and proliferation, cell death
and survival (5 molecules; score 11; Figure 6A). For H37Rv
infection, the top two networks were: (1) cellular movement,
hematological system development and function, and immune
cell trafficking (14 molecules; score 29; Figure 6B, left); and
(2) cancer, cell death, and survival, and cellular movement (9
molecules; score 16; Figure 6B, right). ForM. bovis infection, the
top two networks were: (1) free radical scavenging, hereditary
disorder, and immunological disease (9 molecules; score 18;
Figure 6C, left); (2) cell death and survival, organismal injury
and abnormalities, and tissue morphology (3 molecules; score 5;
Figure 6C, right). All networks showed significant differences in
the specific members that were up-regulated, un-regulated, or
down-regulated upon BCG, H37Rv, orM. bovis infection.
Similarly, IPA analysis identified numerous significantly-
affected canonical pathways. The phagosome maturation
pathway was differentially affected by BCG and H37Rv
treatments (Figure S1A). Moreover, several proteins were
similarly regulated by virulent H37Rv andM. bovis: differentially
regulated proteins CCL20 and ICAM1, both involved in
the TNF signaling pathway (Figure S1B); differentially
regulated proteins NCF1 and ICAM1, both involved in the
leukocyte transendothelial migration pathway (Figure S1C).
Additional representative canonical pathways, such as EIF2
signaling, rheumatoid arthritis, PPAR signaling pathway, SNARE
interactions in vesicular transport, peroxisome, and chemokine
signaling pathway, were also differentially regulated upon
infection (Table S5).
String Analysis
The 60 differently expressed proteins were analyzed using
STRING-10 with a medium confidence score threshold
FIGURE 7 | STRING analysis revealing the interaction partners of the significantly altered proteins. Red color indicates 31 proteins involved in vesicle
category.
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of 0.4, and an interactome network was built for these
set of proteins to find out protein-protein interaction and
predict functional associations. We found that proteins
involved in signaling pathway, migration pathway, vesicular
transport, and intermediary metabolism interacted with
each other as well as their partners; in addition, SEC22b
cannot be founded by STRING-10. We also found that 31
proteins were involved in vesicle category and that most of
them interacted with each other as well as their partners
(Figure 7).
Quantitative Real-Time (qRT)-PCR
Validation
To confirm the differential expression of the cellular
proteome during MTBC-infection, 28 genes based on
interest and different ratios were selected and assessed via
qRT-PCR (Figure 8). The ratios from qRT-PCR analysis
were in accordance with those obtained from the iTRAQ
approach.
FIGURE 8 | Real-time RT-PCR analysis of significantly altered proteins
in THP-1 cells infected by MTBC (10 MOI) or a mock. (A) BCG in black
bars, (B) H37Rv in gray bars, (C) M. bovis in dark gray bars.
DISCUSSION
To date, the proteomics field has increasingly focused on
intrinsically different proteins during host-pathogen interactions
induced by MTBC infection. A variety of proteomic approaches
have been applied to cells stimulated by infection (Rao et al.,
2009; Li et al., 2011; Kaewseekhao et al., 2015; Saquib et al.,
2015; Diaz et al., 2016; Long et al., 2016) or mycobacterial
bioactive lipids (Shui et al., 2008). Comparisons of the results
obtained in the current study with a previous proteomic assay
of the BCG infected THP-1 cell (Lee et al., 2010) indicated
that 392 common proteins and were identified and measured
in both studies. There was good correlation between the
two studies: 367 proteins were indicated as not significantly
regulated in both assays and no proteins were indicated as
significantly up-regulated in one assay but down-regulated in
the other. Interestingly, lysosome-associated protein- LAMP-2
was tested as well as LAMTOR2 is discovered up- regulated in
present BCG-infected cell study. There was no common protein
comfirmed as significantly regulated in both studies, partly
because the different time and method for purification of BCG
phagosomes. Remarkably, differentially regulated proteins in
these studies were associated with hemopoiesis, vesicle transport,
apoptosis, phagosome maturation, immune cell trafficking, and
the inflammatory response. Not all processes were affected by
all MTBC strains or in different cell type, especially the virulent
M. bovis-human host interaction. Thus, the current study was
conducted to directly compare a live vaccine strain and two
virulent strains, H37Rv andM. bovis, in a common cell type that
had been previously used.
It is known that different MTB genetic groups can exhibit
different features that affect protein extraction (Bespyatykh et al.,
2016). The well-studied laboratory H37Rv strain cultured in cell
culture media shows no net increase in viable bacilli numbers
out to 7 days (Ackart et al., 2014). Because we used the same
workflow both for three different strains, to be sure of its
effectiveness we compared the number of identifed proteins
within functional categories. It allows us to conclude that the
differences in protein abundance we observed from MTBC-
infection are independent from our workflow and reflect the
true physiological characteristics of pathogens. Upon cellular
infection, the two virulent strains induced host alterations were
major differences in the proteins and pathways, comparing
responses to mock and vaccine strain BCG. It was shown
that SOD2, KTR9, CCL20, and ICAM1 were significantly up-
regulated by H37Rv and M. bovis infections. Moreover, two of
these proteins, CCL20 and ICAM1 which involved the TNF
signaling pathway, were prominently upregulated at the mRNA
level via qRT-PCR (Figure 8). The group of virulence H37Rv
infection showed a higher dysregulation distribution of proteins
across functional categories, in agreement with the results of Li
et al. (2011).
Global protein analyses of the post translational modifications
(PTMs) have deciphered that PTMs are associated with
pathogenicity in bacteria, including phosphorylation (Calder
et al., 2016), lysine succinylation (Yang et al., 2015), and
glycosylation (Hare et al., 2017). It is striking that IFIT1 and
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IFIT3, two interferon-induced proteins involved in interferon
signaling (Hare et al., 2015, 2017), showed significant up-
regulation among theH37Rv-induced proteins.Moreover, several
proteins involved in PTMs were differently regulated by
M. bovis-infection, including RNF20, YARS2, and TMSB10
(Table 1). A study has demonstrated that LprG of M. bovis
interacted with LAMP-3 to modulate the traffic machinery
in cells (Vázquez et al., 2016). LAMTOR2 might be a
potential target for endosome trafficking events of M. bovis
by interacting with bacterial proteins. Since a small amount
of enzyme can promote high efficiency response, the enzyme
MTHFD2, SOD2, YARS2, and RNF20 were differentially
regulated during M. bovis infection. Moreover, two of these
proteins, SOD2 and MTHFD2 which involved in metabolism
pathways, were prominently upregulated at the mRNA level
via qRT-PCR (Figure 8). Particularly, the analysis of canonical
pathways revealed that bifunctional methylenetetrahydrofolate
dehydrogenase (MTHFD2) was involved in the pathways
“tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate,
histidine degradation III, and folate transformations I” and can
directly interact with each other (Figure 6C, right), suggesting
that MTHFD2 enzyme is effective upon M. bovis infection.
Among the 61 differently regulated proteins, the interactome
network revealed that 27 proteins interacted with each other. The
vacuolar protein VPS26A, involved in endocytosis, interacted
with TBC1D9B uniquely induced by M. bovis. Meanwhile, five
common proteins induced by virulence strains-M. tb and M.
bovis involved in signaling pathway interacted with each other
(Figure 9). Our findings have contributed to a large number of
cellular proteins that are differentially regulated byM. tb andM.
bovis.
The successful establishment and maintenance of bacterial
infection not only depends on the pathogenic bacteria’s ability
but also the host cell’s defense response. Different strains of the
same species can also induce differences in pathology (Price et al.,
2003; Jeon et al., 2008; Shah et al., 2013; Bai et al., 2015; Zhou
et al., 2016). The present proteomic profiles of cellular proteins
are beneficial to improving and enhancing understanding of the
existing network of cross-talk mechanisms between the host and
pathogen (Sambarey et al., 2013; Wu et al., 2014; Diaz et al., 2016;
Li et al., 2016; Vázquez et al., 2016).
In conclusion, our study presents for the first application of
proteomic analysis to compare whole cellular protein alterations
induced by virulent M. bovis infections. The lysosomal adaptor
FIGURE 9 | STRING analysis revealing 27 interaction partners of the significantly altered proteins. The blue oval indicates unique proteins involved in
M. bovis induced proteins; the red square indicates the common proteins involved in virulent strains-H37Rv and M. bovis induced proteins.
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LAMTOR2 might be a potential target for endosome trafficking
events of M. bovis. The MTHFD2, VPS26A, and TBC1D9B
proteins uniquely induced by virulent M. bovis infections might
reveal novel biomarkers, which are also critical in cattle-
to-human transmission and diagnosis of TB. Even though
our fndings do not have an immediate proofs to elucidate
the mechanism of how M. bovis interact with the host,
they represent the proof-of-concept that virulent M. bovis
will induce human cells with a characteristic proteome. To
further characterize the intimate and persistent connection
between these common mycobacterial pathogens, we will still
need to molecularly explore the host-pathogen landscape,
identify molecules with anti-TB function, and determine the
means to clinically treat based on insight gleaned from
pathogen-host interactions at both a global and a targeted
level.
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